North American COVID-19 Diagnostics Market
North American COVID-19 Diagnostics Market Size, Share & Trends Analysis Report by Type (Instruments, Reagents & Kits, and Laboratory Testing Services), by Technology Type (PCR Test, Antigen Test, Serology Test, and Rapid/ PoC Test), by Sample Type (Oropharyngeal & Nasopharyngeal Swabs, Blood, Urine, Saliva, and Others), and by End-User (Laboratories, Hospitals, Diagnostic Centers & Clinics, and Research Institutes) and Forecast, 2020-2026 Update Available - Forecast 2024-2030
North American COVID-19 diagnostics market is estimated to see a decline in CAGR of 24.7% during the forecast period. North America is anticipated to make huge contribution to the global COVID-19 diagnostics market. The rising number of daily cases, considerable increase in demand for early diagnosis, and continuous advancement in diagnostics procedure are the key factors contributing to the high share of the market in the region. The key players operating in the region are making new product launches to accelerate the speed of diagnostics procedure. For instance, in July 2020, T2 Biosystems, Inc. announced the launch of the FDA-approved T2SARS-CoV-2 Panel, a COVID-19 molecular diagnostic test which provides results in less than 2 hours. Moreover, the government support for speeding up the procedure for testing is another major reason contributing to the regional market growth.
North American COVID-19 diagnostics market is segmented on the basis of technology type, end-use, sample type, and product type. By technology type, the market is further segmented into PCR Test, Antigen Test, Serology Test, and Rapid/ PoC Test. By end-use, the COVID-19 diagnostic market is divided into laboratories, hospitals, diagnostic centers & clinics, and research institutes. By product type, the market is further segmented into instruments, reagents & kits, and laboratory testing services. By Sample type, the market is divided into oropharyngeal & nasopharyngeal swabs, blood, urine, saliva, and others. North America's COVID-19 diagnostics market is segmented on the basis of countries, the US and Canada. The US held the largest market value, around 90%, in the North American dietary supplement for the PMS market due to the growing number of daily cases, significant growth in demand for early diagnosis, and continuous advancement in diagnostics procedures.
The companies which are contributing to the growth of the North American COVID-19 diagnostics market include Abbott Laboratories Inc., Quidel Corp., Thermo Fisher Scientific Inc., Laboratory Corp. of America Holdings, and PerkinElmer, Inc. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups, and technological advancements to stay competitive in the market. For instance, in April 2020, Abbott Laboratories Inc. introduced a lab-based serology blood test on its ARCHITECT i1000SR and i2000SR laboratory instruments for the detection of an antibody and to determine the previous infection. The serology test was granted the EUA in the US on April 26, 2020, and CE Mark on April 24, 2020.
Research Methodology
The market study of the North American COVID-19 diagnostics market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
- Financial reports of companies involved in the market.
- Whitepapers, research-papers, and news blogs.
- Company websites and their product catalog.
The report provides an in-depth analysis of market size, various services offered by the players, and market opportunity. The report will serve as a source for 360-degree analysis of the market delivering insights for making better business decisions.
Market Segmentation
- North American COVID-19 Diagnostics Market Research and Analysis by Type
- North American COVID-19 Diagnostics Market Research and Analysis by Technology Type
- North American COVID-19 Diagnostics Market Research and Analysis by Sample Type
- North American COVID-19 Diagnostics Market Research and Analysis by End-User
The Report Covers
- Comprehensive research methodology of the North American COVID-19 diagnostics market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the North American COVID-19 diagnostics market.
- Insights about market determinants which are stimulating the North American COVID-19 diagnostics market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. North American COVID-19 Diagnostics Market by Type
5.1.1. Instruments
5.1.2. Reagents & Kits
5.1.3. Laboratory Testing Services
5.2. North American COVID-19 Diagnostics Market by Technology Type
5.2.1. PCR Test
5.2.2. Antigen Test
5.2.2.1. Chromatographic Immunoassay
5.2.2.2. Fluorescent Immunoassay
5.2.2.3. Chemiluminescent Immunoassay
5.2.3. Serology Test
5.2.3.1. Enzyme-Linked Immunosorbent Assay (ELISA)
5.2.3.2. Neutralization
5.2.3.3. Chemiluminescent Immunoassay
5.2.4. Rapid/ PoC Test
5.3. North American COVID-19 Diagnostics Market by Sample Type
5.3.1. Oropharyngeal & Nasopharyngeal Swabs
5.3.2. Blood
5.3.3. Urine
5.3.4. Saliva
5.3.5. Others (Sperm)
5.4. North American COVID-19 Diagnostics Market by End-Users
5.4.1. Laboratories
5.4.2. Hospitals
5.4.3. Diagnostic Centers & Clinics
5.4.4. Research Institutes
6. Regional Analysis
6.1. United States
6.2. Canada
7. Company Profiles
7.1. Abbott Laboratories Inc.
7.2. Beckman Coulter, Inc.
7.3. Cellex Inc.
7.4. Cepheid Inc.
7.5. Chembio Diagnostics Systems Inc.
7.6. Epitope Diagnostics, Inc.
7.7. Hologic Inc.
7.8. Laboratory Corp. of America Holdings
7.9. Luminex Corp.
7.10. PerkinElmer, Inc.
7.11. Quidel Corp.
7.12. Thermo Fisher Scientific, Inc.
1. NORTH AMERICAN COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
2. NORTH AMERICAN COVID-19 DIAGNOSTICS INSTRUMENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
3. NORTH AMERICAN COVID-19 DIAGNOSTICS REAGENTS & KITS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
4. NORTH AMERICAN COVID-19 DIAGNOSTICS LABORATORY TESTING SERVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
5. NORTH AMERICAN COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY TYPE, 2019-2026 ($ MILLION)
6. NORTH AMERICAN COVID-19 DIAGNOSTICS PCR TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
7. NORTH AMERICAN COVID-19 DIAGNOSTICS ANTIGEN TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
8. NORTH AMERICAN COVID-19 DIAGNOSTICS SEROLOGY TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
9. NORTH AMERICAN COVID-19 DIAGNOSTICS RAPID/POC TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
10. NORTH AMERICA COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY SAMPLE TYPE, 2019-2026 ($ MILLION)
11. NORTH AMERICAN COVID-19 DIAGNOSTICS THROUGH OROPHARYNGEAL & NASOPHARYNGEAL SWABS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
12. NORTH AMERICAN COVID-19 DIAGNOSTICS THROUGH BLOOD MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
13. NORTH AMERICAN COVID-19 DIAGNOSTICS THROUGH URINE MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
14. NORTH AMERICAN COVID-19 DIAGNOSTICS THROUGH SALIVA MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
15. NORTH AMERICAN COVID-19 DIAGNOSTICS THROUGH OTHER SAMPLES MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
16. NORTH AMERICA COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USERS, 2019-2026 ($ MILLION)
17. NORTH AMERICAN COVID-19 DIAGNOSTICS IN HOSPITALS SWABS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
18. NORTH AMERICAN COVID-19 DIAGNOSTICS IN DIAGNOSTIC CENTERS AND URGENT CARE CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
19. NORTH AMERICAN COVID-19 DIAGNOSTICS IN RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
20. NORTH AMERICAN COVID-19 DIAGNOSTICS IN LABORATORIES MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
21. NORTH AMERICA COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
22. US COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
23. US COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY TYPE, 2019-2026 ($ MILLION)
24. US COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY SAMPLE TYPE, 2019-2026 ($ MILLION)
25. US COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USERS, 2019-2026 ($ MILLION)
26. CANADA COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
27. CANADA COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY TYPE, 2019-2026 ($ MILLION)
28. CANADA COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY SAMPLE TYPE, 2019-2026 ($ MILLION)
29. CANADA COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USERS, 2019-2026 ($ MILLION)
1. NORTH AMERICAN COVID-19 DIAGNOSTICS MARKET SIZE, 2019-2026 ($ MILLION)
2. NORTH AMERICAN COVID-19 DIAGNOSTICS MARKET SHARE BY COUNTRY, 2019 VS 2026 (%)
3. NORTH AMERICAN COVID-19 DIAGNOSTICS MARKET SHARE BY TYPE, 2019 VS 2026 (%)
4. NORTH AMERICAN COVID-19 DIAGNOSTICS MARKET SHARE BY TECHNOLOGY TYPE, 2019 VS 2026 (%)
5. NORTH AMERICAN COVID-19 DIAGNOSTICS MARKET SHARE BY SAMPLE TYPE, 2019 VS 2026 (%)
6. NORTH AMERICAN COVID-19 DIAGNOSTICS MARKET SHARE BY END-USERS, 2019 VS 2026 (%)
7. US COVID-19 DIAGNOSTICS MARKET SIZE, 2019-2026 ($ MILLION)
8. CANADA COVID-19 DIAGNOSTICS MARKET SIZE, 2019-2026 ($ MILLION)
